• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对信号转导与转录激活因子3的SRC同源2结构域的磷酸肽结合决定簇的研究。一种高亲和力肽抑制剂的开发。

Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor.

作者信息

Coleman David R, Ren Zhiyong, Mandal Pijus K, Cameron Arlin G, Dyer Garrett A, Muranjan Seema, Campbell Martin, Chen Xiaomin, McMurray John S

机构信息

Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

出版信息

J Med Chem. 2005 Oct 20;48(21):6661-70. doi: 10.1021/jm050513m.

DOI:10.1021/jm050513m
PMID:16220982
Abstract

Signal transducer and activator of transcription 3 (Stat3) is a cytosolic transcription factor that relates signals from the cell membrane directly to the nucleus where it, in complex with other proteins, initiates the transcription of antiapoptotic and cell cycling genes, e.g., Bcl-x(L) and cyclin D1. In normal cells Stat3 transduces signals from cytokines such as IL-6 and growth factors such as the epidermal growth factor. Stat3 is constitutively activated in a number of human tumors. Antisense and dominant negative gene delivery result in apoptosis and reduced cell growth, thus this protein is an attractive target for anticancer drug design. As part of our research on the design of Src homology 2 (SH2) directed peptidomimetic inhibitors of Stat3, in this paper we describe structure-activity relationship studies that provide information on the nature of peptide-protein interactions of a high-affinity phosphopeptide inhibitor of Stat3 dimerization and DNA binding, Ac-Tyr(PO3H2)-Leu-Pro-Gln-Thr-Val-NH2, peptide 1. There is a hydrophobic surface on the SH2 domain that can accommodate lipophilic groups on the N-terminus. Of the amino acids tested, leucine provided the highest affinity at pY+1 and its main chain NH is involved with a hydrogen bond with Stat3, presumably Ser636. cis-3,4-Methanoproline is optimal as a backbone constraint at pY+2. The side chain amide protons of Gln are required for high-affinity interactions. The C-terminal dipeptide, Thr-Val, can be replaced with groups ranging in size from methyl to benzyl. We synthesized a phosphopeptide incorporating groups that provided increases in affinity at each position. Thus, hydrocinnamoyl-Tyr(PO3H2)-Leu-cis-3,4-methanoPro-Gln-NHBn, 50, was the highest affinity peptide, exhibiting an IC50 of 125 nM versus 290 nM for peptide 1 in a fluorescence polarization assay.

摘要

信号转导及转录激活因子3(Stat3)是一种胞质转录因子,它将来自细胞膜的信号直接传递至细胞核,在细胞核中它与其他蛋白质形成复合物,启动抗凋亡和细胞周期基因(如Bcl-x(L)和细胞周期蛋白D1)的转录。在正常细胞中,Stat3转导来自细胞因子(如IL-6)和生长因子(如表皮生长因子)的信号。Stat3在多种人类肿瘤中持续激活。反义基因和显性负性基因传递可导致细胞凋亡并减少细胞生长,因此该蛋白是抗癌药物设计的一个有吸引力的靶点。作为我们对Src同源2(SH2)导向的Stat3拟肽抑制剂设计研究的一部分,本文描述了构效关系研究,这些研究提供了关于Stat3二聚化和DNA结合的高亲和力磷酸肽抑制剂Ac-Tyr(PO3H2)-Leu-Pro-Gln-Thr-Val-NH2(肽1)的肽-蛋白质相互作用性质的信息。SH2结构域上有一个疏水表面,可容纳N端的亲脂基团。在所测试的氨基酸中,亮氨酸在pY+1处提供了最高亲和力,其主链NH与Stat3(可能是Ser636)形成氢键。顺式-3,4-甲桥脯氨酸作为pY+2处的主链约束是最佳的。Gln的侧链酰胺质子是高亲和力相互作用所必需的。C端二肽Thr-Val可被大小从甲基到苄基不等的基团取代。我们合成了一种磷酸肽,其在每个位置引入的基团都提高了亲和力。因此,氢化肉桂酰-Tyr(PO3H2)-Leu-顺式-3,4-甲桥脯氨酸-Gln-NHBn(50)是亲和力最高的肽,在荧光偏振测定中,其IC50为125 nM,而肽1的IC50为290 nM。

相似文献

1
Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor.针对信号转导与转录激活因子3的SRC同源2结构域的磷酸肽结合决定簇的研究。一种高亲和力肽抑制剂的开发。
J Med Chem. 2005 Oct 20;48(21):6661-70. doi: 10.1021/jm050513m.
2
Structural basis for the binding of high affinity phosphopeptides to Stat3.高亲和力磷酸肽与Stat3结合的结构基础。
Biopolymers. 2008;90(1):69-79. doi: 10.1002/bip.20901.
3
A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.一种新型非磷酸化潜在抗肿瘤肽可抑制信号转导和转录激活因子3(STAT3)的生物学活性。
Biochimie. 2009 Aug;91(8):996-1002. doi: 10.1016/j.biochi.2009.05.006. Epub 2009 May 24.
4
Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.信号转导与转录激活因子的构象受限拟肽抑制剂。3:评估与分子建模。
J Med Chem. 2009 Apr 23;52(8):2429-42. doi: 10.1021/jm801491w.
5
Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.采用基于α-甲基苯丙氨酰基的磷酸酪氨酸模拟物设计与合成构象受限的Grb2 SH2结构域结合肽
J Med Chem. 2005 Feb 10;48(3):764-72. doi: 10.1021/jm0492709.
6
Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.作为Src SH2结构域结合抑制剂的pTyr-Glu-Glu-Ile的构象受限肽类似物。
J Med Chem. 2004 Jun 3;47(12):3131-41. doi: 10.1021/jm040008+.
7
Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3.纳入靶向信号转导与转录激活因子3的SH2结构域的磷酸肽中的谷氨酰胺模拟物的结构-亲和力关系。
J Med Chem. 2009 Oct 8;52(19):6126-41. doi: 10.1021/jm901105k.
8
Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.作为Src SH2结构域抑制剂的四肽配体设计
Bioorg Med Chem. 2004 Feb 15;12(4):779-87. doi: 10.1016/j.bmc.2003.10.060.
9
Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.氨基芳基 SH2 磷酸肽配体高亲和力的结构基础。
J Mol Biol. 1998 Jun 19;279(4):1013-22. doi: 10.1006/jmbi.1998.1790.
10
Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.蛋白酪氨酸磷酸酶SHP-1的N端SH2结构域线性和环状磷酸肽配体的设计与生物学评价
J Med Chem. 2005 Mar 10;48(5):1528-39. doi: 10.1021/jm049151t.

引用本文的文献

1
Difluorocarbene-induced [1,2]- and [2,3]-Stevens rearrangement of tertiary amines.二氟卡宾诱导的叔胺的[1,2] - 和[2,3] - 史蒂文斯重排反应
Nat Commun. 2024 Jun 5;15(1):4794. doi: 10.1038/s41467-024-49054-x.
2
Complement factor H inhibits endothelial cell migration through suppression of STAT3 signaling.补体因子H通过抑制信号转导和转录激活因子3(STAT3)信号传导来抑制内皮细胞迁移。
Exp Ther Med. 2023 Jul 10;26(2):408. doi: 10.3892/etm.2023.12107. eCollection 2023 Aug.
3
MEKK4-mediated Phosphorylation of HOXA10 at Threonine 362 facilitates embryo adhesion to the endometrial epithelium.
MEKK4介导的苏氨酸362位点HOXA10磷酸化促进胚胎与子宫内膜上皮的黏附。
Cell Death Discov. 2022 Oct 10;8(1):415. doi: 10.1038/s41420-022-01203-1.
4
Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibility.基于结构的虚拟配体筛选结合 SH2 结构域柔性鉴定新型 STAT3 小分子抑制剂。
Pharmacol Res. 2021 Jul;169:105637. doi: 10.1016/j.phrs.2021.105637. Epub 2021 Apr 29.
5
In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides.体外分析:细胞穿透肽的朋友还是敌人。
Int J Mol Sci. 2020 Jul 2;21(13):4719. doi: 10.3390/ijms21134719.
6
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.造血系统癌症中致癌性 STAT3 和 STAT5 信号通路的药理学抑制作用
Cancers (Basel). 2020 Jan 18;12(1):240. doi: 10.3390/cancers12010240.
7
A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3.一种噻唑衍生的冬凌草甲素类似物通过直接和变构抑制 STAT3 发挥抗肿瘤活性。
J Biol Chem. 2019 Nov 15;294(46):17471-17486. doi: 10.1074/jbc.RA119.009801. Epub 2019 Oct 8.
8
Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development.STAT3 的结构生物学及其对癌症治疗开发的意义。
Int J Mol Sci. 2018 May 28;19(6):1591. doi: 10.3390/ijms19061591.
9
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.骨髓增殖性肿瘤、外周T细胞白血病和淋巴瘤中新兴的治疗靶点
Expert Opin Ther Targets. 2018 Jan;22(1):45-57. doi: 10.1080/14728222.2018.1406924. Epub 2017 Nov 24.
10
Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity.利用可穿透细胞、磷酸酶稳定的磷酸肽模拟物靶向信号转导子和转录激活子6(STAT6)的Src同源2(SH2)结构域可有效抑制Tyr641磷酸化和转录活性。
J Med Chem. 2015 Nov 25;58(22):8970-84. doi: 10.1021/acs.jmedchem.5b01321. Epub 2015 Nov 9.